(Q36677168)

15 August 2017

EphA2 overexpression is associated with angiogenesis in ovarian cancer (English)

1 reference

15 August 2017

1 reference

1 reference

Michael S Kinch

9

0 references

Anil K. Sood

10

object named as

Anil K Sood

1 reference

15 August 2017

Yvonne G Lin

1

1 reference

15 August 2017

Liz Y Han

2

1 reference

15 August 2017

Aparna A Kamat

3

1 reference

15 August 2017

William M Merritt

4

1 reference

15 August 2017

Charles N Landen

5

1 reference

15 August 2017

Michael T Deavers

6

1 reference

15 August 2017

Mavis S Fletcher

7

1 reference

15 August 2017

Diana L Urbauer

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

109

1 reference

15 August 2017

2

1 reference

15 August 2017

332-340

1 reference

15 August 2017

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

Differential regulation of EphA2 in normal and malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Eph receptor signalling casts a wide net on cell behaviour

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

EphA2 expression is associated with aggressive features in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Overexpression of the EphA2 tyrosine kinase in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

EphA2 as a target for ovarian cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

The ephrins and Eph receptors in angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

'Eph'ective signaling: forward, reverse and crosstalk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Functional role of matrix metalloproteinases in ovarian tumor cell plasticity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

A novel putative tyrosine kinase receptor encoded by the eph gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Ephrins and their receptors: a repulsive topic?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

The influence of microvessel density on ovarian carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Ovarian cancer p53 mutation is associated with tumor microvessel density

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

The organ microenvironment and cancer metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22415

7 January 2021

Identifiers

DOI

10.1002/CNCR.22415

1 reference

15 August 2017

1 reference